Finance

Lists
Why is BVF down 4,54%?
Dive Deeper
BVF:FRA
Bausch Health Companies Inc
7,46 €
-4,54%
(-0,36) 1D
20 қар., 22:00:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BVF...
Open
7,46 €
High
7,46 €
Low
7,46 €
Mkt. cap
3,09 млрд
Avg. vol.
190,00
Volume
0,00
52-wk high
7,99 €
52-wk low
3,66 €
No. of employees
20 мың
Open
7,46 €
High
7,46 €
Low
7,46 €
Mkt. cap
3,09 млрд
Avg. vol.
190,00
Volume
0,00
52-wk high
7,99 €
52-wk low
3,66 €
No. of employees
20 мың
News stories
From web sources and news partners
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20,3 мың
Founded1959
HeadquartersЛавал, Квебек, Канада
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
2,80 млрд
2,52 млрд
2,85 млрд
2,94 млрд
Cost of goods sold
798,00 млн
738,00 млн
772,00 млн
735,00 млн
Cost of revenue
798,00 млн
738,00 млн
772,00 млн
735,00 млн
Research and development expenses
161,00 млн
163,00 млн
173,00 млн
141,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
880,00 млн
860,00 млн
907,00 млн
834,00 млн
Operating expense
1,28 млрд
1,26 млрд
1,30 млрд
1,20 млрд
Total operating expenses
2,08 млрд
2,00 млрд
2,08 млрд
1,94 млрд
Operating income
721,00 млн
521,00 млн
775,00 млн
1,01 млрд
Other non operating income
-
-
-
-
EBT including unusual items
56,00 млн
-1,35 млрд
348,00 млн
597,00 млн
EBT excluding unusual items
322,00 млн
118,00 млн
383,00 млн
620,00 млн
Income tax expense
159,00 млн
77,00 млн
88,00 млн
151,00 млн
Effective tax rate
283,93%
-5,69%
25,29%
25,29%
Other operating expenses
-
1,00 млн
-
-2,00 млн
Net income
-112,00 млн
-1,42 млрд
258,00 млн
436,00 млн
Net profit margin
-4,01%
-56,38%
9,05%
14,82%
Earnings per share
1,10
0,78
1,26
1,77
Interest and investment income
9,00 млн
10,00 млн
11,00 млн
13,00 млн
Interest expense
-397,00 млн
-402,00 млн
-396,00 млн
-398,00 млн
Net interest expenses
-388,00 млн
-392,00 млн
-385,00 млн
-385,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,01 млрд
816,00 млн
1,06 млрд
1,29 млрд
Gain or loss from assets sale
-
-3,00 млн
-
-1,00 млн
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары